ETC
VIR icon

Exchange Traded Concepts’s Vir Biotechnology VIR Stock Holding History

Exchange Traded Concepts’s Portfolio VIR Stock Details VIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-26,701
Closed -$655K – 1517
2023
Q2 		$655K Hold
26,701
– – 0.02% 502
2023
Q1 		$621K Sell
26,701
-21,960
-45% -$562K 0.02% 483
2022
Q4 		$1.23M Buy
48,661
+1,480
+3% +$36.3K 0.04% 270
2022
Q3 		$910K Buy
+47,181
New +$1.2M 0.03% 289
2021
Q2 		– Sell
-171
Closed -$9K – 1224
2021
Q1 		$9K Buy
+171
New +$9.22K ﹤0.01% 993

Other funds holding VIR

SIAU
SB Investment Advisers (UK) London, United Kingdom $7.66B AUM 20.12% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
GF
Gates Foundation Seattle, Washington $43.5M AUM 14.19% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Exchange Traded Concepts's VIR Position: Q3 2023 in Review

Exchange Traded Concepts sold out of Vir Biotechnology (VIR) in Q3 2023, closing a stake of 26,701 shares — an estimated $655K sold.

Exchange Traded Concepts first reported a position in VIR in Q1 2021 and held it in 5 quarters. The position peaked at $1.23M in Q4 2022. 214 funds tracked by Wall St. Rank hold VIR as of Q3 2023.

  • Exchange Traded Concepts reported no remaining Vir Biotechnology position as of Q3 2023 after selling out during the quarter.
  • Exchange Traded Concepts sold 26,701 Vir Biotechnology shares in Q3 2023, an estimated $655K.
  • Exchange Traded Concepts first reported a position in Vir Biotechnology in Q1 2021 and held it in 5 quarters.
  • Exchange Traded Concepts's Vir Biotechnology position peaked at $1.23M in Q4 2022.
  • 214 funds tracked by Wall St. Rank held Vir Biotechnology as of Q3 2023.

Based on Exchange Traded Concepts's 13F filing for Q3 2023, filed 18 Oct 2023.